Prepared by Capital Hunter analysts:
Venture capital investment dropped sharply this period, with companies only raising a mere $178 million, the smallest amount of capital in a given week since July of 2005, and the 60% drop from last period’s $445 million is the largest week-over-week decline since we started the newsletter back in 2003. Software and life science investment were predictably the top destinations for venture capital, but outside a few digital media deals other sectors were largely shut out. In a show of just how pathetic deal flow was, the largest financing of the period, Chimerix, received just $23.1 million, which under normal circumstances would not even come close to the top weekly deals and would probably not even merit discussion. Chimerix, which by the way develops orally-available bioactive medicines, raised the Series D funding from notable biotech backers Canaan Partners, Sanderling Ventures, Asset Management Company and Frazier Healthcare Ventures in order to continue research and development. The only other financing above $20 million was infrastructure software company Gearworks, which raised $21.4 million in Series B funding in order to expand their mobile workforce solutions overseas as well as expand marketing and sales in their home market. Hopefully this dreadful state of affairs will correct itself for our next newsletter, but we cannot be sure. We still expect to see $300-$450 million a week for at least the next few months, but if we come across anything that changes our assumptions we will let you know.
The IPO market was just as bad (actually worse) as venture capital investment this period, with the only offering being a US Dollar Index Trust, which we do not normally cover here at Capital Hunter. Hopefully this state of affairs is just a lull and not the start of a new trend. Without further ado, here is the index trust that listed this period:
Powershares DB US Dollar Index Trust
AMEX:UUP priced at $25 million and is an exchange traded fund (ETF) that invests in US dollar futures contracts.
Please come visit our web site at
CapitalHunter.com. We have made improvements to both the look and functionality of our web site, including business resources, glossary terms, and other helpful information provided free of charge for the budding entrepreneur. For private equity firms, consulting firms, business journals, and individuals looking to do research on venture backed companies, you can still gain complete access to our entire database for $59 a quarter and $199 a year.